2008
DOI: 10.1016/j.vaccine.2008.09.045
|View full text |Cite
|
Sign up to set email alerts
|

Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
99
0
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 123 publications
(101 citation statements)
references
References 83 publications
1
99
0
1
Order By: Relevance
“…As a result, activation of a class of innate pathogen receptors called pattern recognition receptors is a central feature of many adjuvant systems (26). This can be readily appreciated in prior studies, which demonstrated that TLR activators, such as LPS, and NOD-like receptor activators, such as aluminum hydroxide, are effective immune adjuvants (15,17,20,(27)(28)(29).…”
Section: Discussionmentioning
confidence: 99%
“…As a result, activation of a class of innate pathogen receptors called pattern recognition receptors is a central feature of many adjuvant systems (26). This can be readily appreciated in prior studies, which demonstrated that TLR activators, such as LPS, and NOD-like receptor activators, such as aluminum hydroxide, are effective immune adjuvants (15,17,20,(27)(28)(29).…”
Section: Discussionmentioning
confidence: 99%
“…It was discovered in the late 1980s that conjugation of Pam3CSS (tripalmitoyl Cys-SerSer) or Pam2CSS (di-O-acylated palmitoyl Cys-Ser-Ser) to peptides derived from bacterial or viral proteins could convert the immunologically inactive peptides into potent vaccines that provided long-lasting protection against bacterial or viral infections in animal models. This effect was enabled by induction of neutralizing antibodies (28,29) and by in vivo priming of epitope-specific cytotoxic T cells and memory T cells (30)(31)(32). Since antibodies to the lipid moieties are not generated in vivo, the immune-enhancing effect of the lipids is believed to be similar to that of a conventional adjuvant, and thus, bacterial lipoprotein/lipopeptidecontaining vaccines are recognized as one category of selfadjuvanting vaccines (21)(22)(23)33).…”
Section: Immune-enhancing Effects Of the N-terminal Lipids Of Rlp2086mentioning
confidence: 99%
“…It was perceived in early days that the lipids simply anchor the lipoproteins/lipopeptides to the surface membrane of immune cells to facilitate the internalization. Recent research suggested that the lipid moieties interact with various TLRs, a type of membranebound pattern recognition receptors (PRRs), to drive the endocytosis of the lipoproteins by antigen-presenting cells (34) and induce various immune responses (21,22,32). PRR is a key component of the innate immune system to identify pathogen-associated molecular patterns (PAMPs) (35).…”
Section: Immune-enhancing Effects Of the N-terminal Lipids Of Rlp2086mentioning
confidence: 99%
“…Individual TLR have distinct pathogen-associated motif specificities, with TLR4 recognizing LPS (1), TLR2 binding bacterial lipopeptides (2), while TLR3 and TLR9 bind viral and bacterial nucleic acids, respectively (3)(4)(5). The use of noninfectious TLR agonists as vaccine adjuvants is a promising approach to generate pathogen-specific adaptive responses (6,7); however, the ability of specific TLR engagement to promote primary and secondary immune responses is not clearly resolved.…”
Section: Tlr2 Engagement On Dendritic Cells Promotes Highmentioning
confidence: 99%